Privacy issues in personalized medicine

Laszlo T. Vaszar, Mildred K. Cho, Thomas A. Raffin

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

Pharmacogenomics is the emerging study of why individuals respond differently to drugs. It aims to replace the current 'one size fits all' therapeutic approach with 'personalized medicine' that will use pharmacogenomic tests to predict drug response. In a simple conceptualization, these tests challenge privacy as a result of two factors: how comprehensive is the test and how is the access to samples or digital information controlled. Point-of-care tests are likely to be limited in scope, fit seamlessly into medical records and do not raise qualitatively new ethical and privacy challenges. In order to define practically relevant pharmacogenomic predictive patterns however, large-scale clinical trials and research on human specimens will be required, resulting in large databases of genomic information. The genomic scans' magnitude, stability, implications to kin and ease of dissemination together represent a qualitatively different challenge compared to traditional, self-limited and often temporally transient medical information.

Original languageEnglish (US)
Pages (from-to)107-112
Number of pages6
JournalPharmacogenomics
Volume4
Issue number2
DOIs
StatePublished - Mar 1 2003

Keywords

  • Biobanks
  • Bioethics
  • Bioinformatics
  • Confidentiality
  • Genome
  • Informed consent
  • Pharmacogenetics
  • Pharmacogenomics
  • Privacy

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology

Fingerprint Dive into the research topics of 'Privacy issues in personalized medicine'. Together they form a unique fingerprint.

  • Cite this